Evidence map›Paper›PMID 26757807›Full record

ArticleBioTechniques2016

Efficient transgenesis mediated by pigmentation rescue in zebrafish.

Itrat Harrold, Seth Carbonneau, Bethany M Moore, Gina Nguyen, Nicole M Anderson, Amandeep S Saini, John P Kanki, Cicely A Jette, Hui Feng

Abstract read
In one paragraph

Article in BioTechniques, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Itrat Harrold *Departments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.
Seth Carbonneau *Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Bethany M MooreDepartments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.
Gina NguyenDepartments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.
Nicole M AndersonDepartments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.
Amandeep S SainiDepartments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.
John P KankiDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Cicely A JetteDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Hui FengDepartments of Pharmacology and Medicine, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA.

Funding

RESEARCH TRAINING IN BLOOD DISEASES AND RESOURCEST32HL007501 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LERNER, ADAM, STEINBERG, MARTIN H. · 1985 to 2018
$5.4M
"Oncorequisite" Genes in MYC-mediated TransformationR00CA134743 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FENG, HUI · 2012 to 2014
$712k
Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2K01DK074555 · NIDDK · UNIVERSITY OF UTAH · PI JETTE, CICELY ANNE · 2006 to 2010
$666k
NCI NIH HHS R00 CA134743NCI NIH HHS R00CA134743NHLBI NIH HHS 5T32HL007501-30NHLBI NIH HHS T32 HL007501NIDDK NIH HHS 1K01DK074555NIDDK NIH HHS K01 DK074555
6 · The paper itself

Abstract

The zebrafish represents a revolutionary tool in large-scale genetic and small-molecule screens for gene and drug discovery. Transgenic zebrafish are often utilized in these screens. Many transgenic fish lines are maintained in the heterozygous state due to the lethality associated with homozygosity; thus, their progeny must be sorted to ensure a population expressing the transgene of interest for use in screens. Sorting transgenic embryos under a fluorescence microscope is very labor-intensive and demands fine-tuned motor skills. Here we report an efficient transgenic method of utilizing pigmentation rescue of nacre mutant fish for accurate naked-eye identification of both mosaic founders and stable transgenic zebrafish. This was accomplished by co-injecting two constructs with the I-SceI meganuclease enzyme into pigmentless nacre embryos: I-SceI-mitfa:mitfa-I-SceI to rescue the pigmentation and I-SceI-zpromoter:gene-of-interest-I-SceI to express the gene of interest under a zebrafish promoter (zpromoter). Pigmentation rescue reliably predicted transgene integration. Compared with other transgenic techniques, our approach significantly increases the overall percentage of founders and facilitates accurate naked-eye identification of stable transgenic fish, greatly reducing laborious fluorescence microscope sorting and PCR genotyping. Thus, this approach is ideal for generating transgenic fish for large-scale screens.

Indexed as

Gene Transfer TechniquesPromoter Regions, GeneticAnimalsAnimals, Genetically ModifiedGenotypeGreen Fluorescent ProteinsMicrophthalmia-Associated Transcription FactorMicroscopy, FluorescencePigmentationZebrafishZebrafish ProteinsGreen Fluorescent ProteinsMicrophthalmia-Associated Transcription Factormitfa protein, zebrafishZebrafish Proteinspigmentation rescuetransgenesiszebrafish

Identifiers

PMID26757807
PMCPMC4768720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.